Welcome

University College London (UCL) ECMC aims to develop new cancer therapies and undertake early phase clinical trials that are fully informed by modern molecular and imaging technologies. There is particular expertise and dedicated facilities for trials of antibody-targeted, radiation, photodynamic and vascular therapies and biomedical informatics.